Private Advisor Group’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,767
| Closed | -$348K | – | 2295 |
|
|
2024
Q3 | $348K | Sell |
1,767
-211
| -11% | -$41.6K | ﹤0.01% | 1841 |
|
|
2024
Q2 | $409K | Buy |
1,978
+273
| +16% | +$56.4K | ﹤0.01% | 1676 |
|
|
2024
Q1 | $462K | Buy |
1,705
+23
| +1% | +$6.23K | ﹤0.01% | 1570 |
|
|
2023
Q4 | $398K | Buy |
+1,682
| New | +$398K | ﹤0.01% | 1606 |
|
|
2022
Q3 | – | Sell |
-1,370
| Closed | -$293K | – | 1960 |
|
|
2022
Q2 | $293K | Buy |
1,370
+39
| +3% | +$8.34K | ﹤0.01% | 1657 |
|
|
2022
Q1 | $378K | Buy |
1,331
+178
| +15% | +$50.6K | ﹤0.01% | 1548 |
|
|
2021
Q4 | $434K | Sell |
1,153
-15,780
| -93% | -$5.94M | ﹤0.01% | 1515 |
|
|
2021
Q3 | $6.99M | Buy |
16,933
+7,878
| +87% | +$3.25M | 0.04% | 406 |
|
|
2021
Q2 | $3.35M | Buy |
9,055
+557
| +7% | +$206K | 0.03% | 554 |
|
|
2021
Q1 | $2.46M | Sell |
8,498
-1,143
| -12% | -$331K | 0.02% | 624 |
|
|
2020
Q4 | $2.41M | Buy |
+9,641
| New | +$2.41M | 0.03% | 599 |
|
|
2020
Q3 | – | Sell |
-256
| Closed | -$45K | – | 1929 |
|
|
2020
Q2 | $45K | Buy |
+256
| New | +$45K | ﹤0.01% | 2157 |
|
|
2017
Q2 | – | Sell |
-32,742
| Closed | -$769K | – | 1397 |
|
|
2017
Q1 | $769K | Buy |
+32,742
| New | +$769K | 0.02% | 624 |
|
|
2014
Q4 | – | Sell |
-5,567
| Closed | -$333K | – | 1015 |
|
|
2014
Q3 | $333K | Hold |
5,567
| – | – | 0.02% | 659 |
|
|
2014
Q2 | $298K | Buy |
+5,567
| New | +$298K | 0.03% | 656 |
|